|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/864 | (2006.01) |
| C12N2750/14143 | (2013.01) | ||
| A61K 38/47 | (2006.01) | ||
| A61K 38/47 | (2013.01) | ||
| A61K 48/00 | (2006.01) | ||
| A61K 48/0058 | (2013.01) | ||
| A61K 35/76 | (2015.01) | ||
| C12N2750/14171 | (2013.01) | ||
| A61P 25/16 | (2006.01) | ||
| A61P 25/16 | (2018.01) | ||
| C12N 9/24 | (2006.01) | ||
| A61K 35/76 | (2013.01) | ||
| C12Y 302/01045 | (2013.01) | ||
| A01K2267/0356 | (2013.01) | ||
| A01K2227/105 | (2013.01) | ||
| C12N 9/2405 | (2013.01) |
| (11) | Number of the document | 3292206 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16724546.3 |
| Date of filing the European patent application | 2016-05-06 | |
| (97) | Date of publication of the European application | 2018-03-14 |
| (45) | Date of publication and mention of the grant of the patent | 2021-12-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/031223 |
| Date | 2016-05-06 |
| (87) | Number | WO 2016/179497 |
| Date | 2016-11-10 |
| (30) | Number | Date | Country code |
| 201562158244 P | 2015-05-07 | US |
| (72) |
PARK, Yung Hee , US
ISACSON, Ole , US
|
| (73) |
Shire Human Genetic Therapies, Inc. ,
300 Shire Way, Lexington, MA 02421,
US
The McLean Hospital Corporation , 115 Mill Street, Belmont, MA 02478, US |
| (54) | GLUCOCEREBROSIDASE GENE THERAPY FOR PARKINSON'S DISEASE |
| GLUCOCEREBROSIDASE GENE THERAPY FOR PARKINSON'S DISEASE |